IBEX Ltd
IBEX Nasdaq Services-Computer Processing & Data Preparation Financials FY2021–FY2026
Last close · Oct 23, 2026
$47.23
0.6%What IBEX Ltd does
No business description yet.
- Legal name
- IBEX Ltd
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K · Sep 10, 2026
- Accession · CIK
- 0001720420-26-000025
0001720420
Revenue and margins
IBEX Ltd had $644M of revenue in fiscal 2026, up 15.4% on the year before.
Net income and earnings per share
From fiscal 2021 to 2026, diluted EPS grew 34.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $31.2M in fiscal 2026, 4.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
IBEX Ltd returned $14.4M to shareholders in fiscal 2026, 46% of free cash flow. The diluted share count fell 5.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably IBEX Ltd can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $48.8M | $57.4M | $62.7M | $15.4M | $32.6M |
| Debt incl. finance leases | $16.5M | $2.0M | $3.7M | $4.1M | $4.2M |
| Net debt / EBITDA | −0.8x | −0.9x | −1.0x | −0.2x | −0.4x |
| Debt / equity | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 16.0x | 51.1x | 76.7x | 28.5x | 58.7x |
| Current ratio | 1.5x | 2.2x | 2.5x | 1.8x | 2.1x |
| Quick ratio | 1.5x | 2.2x | 2.5x | 1.8x | 2.1x |
| Total assets | $294M | $293M | $294M | $273M | $309M |
| Total liabilities | $181M | $143M | $128M | $139M | $139M |
| Shareholders' equity | $113M | $150M | $166M | $134M | $170M |
| Net debt (− = net cash) | −$32.4M | −$55.5M | −$59.0M | −$11.3M | −$28.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✓ | ✓ | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | — | ✓ | ✕ | ✕ | ✓ |
| Current ratio rose | — | — | ✓ | ✓ | ✕ | ✓ |
| Share count didn't rise | — | ✕ | ✕ | ✓ | ✓ | ✓ |
| Gross margin rose | — | — | — | — | — | — |
| Revenue rose relative to assets | — | — | ✓ | ✕ | ✓ | ✓ |
| F-score | — / 3 | — / 4 | 7 / 8 | 6 / 8 | 6 / 8 | 8 / 8 |
| Accruals ratio | — | −6.3% | −3.5% | −0.8% | −3.1% | −4.4% |
| Altman Z'' | — | 1.28 | 3.44 | 4.57 | 4.05 | 5.24 |
6 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $443M | $493M | $523M | $509M | $558M | $644M |
| Operating income | $17.0M | $20.6M | $40.5M | $39.4M | $46.6M | $55.0M |
| Interest expense | $1.9M | $1.3M | $0.8M | $0.5M | $1.6M | $0.9M |
| Pretax income | $15.2M | $19.4M | $40.3M | $41.0M | $45.9M | $54.3M |
| Income tax | $2.1M | −$2.1M | $8.7M | $7.3M | $9.1M | $8.0M |
| Net income | $13.1M | $21.5M | $31.6M | $33.7M | $36.9M | $46.3M |
| Net income to common | — | — | $31.6M | $33.7M | $36.9M | $46.3M |
| Diluted EPS | $0.71 | $1.15 | $1.67 | $1.84 | $2.36 | $3.13 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.01B |
| Cash flow | ||||||
| Cash from operations | $16.1M | $40.0M | $41.9M | $35.9M | $45.7M | $59.0M |
| Capital expenditure | $20.8M | $25.9M | $19.0M | $8.9M | $18.4M | $27.8M |
| Free cash flow | −$4.7M | $14.1M | $22.9M | $27.0M | $27.3M | $31.2M |
| Depreciation and amortization | $14.1M | $18.1M | $19.0M | $19.5M | $17.2M | $19.9M |
| Stock-based compensation | $5.4M | $1.9M | $4.6M | $3.8M | $5.4M | $7.7M |
| Share buybacks | $0.0M | $3.4M | $0.3M | $21.6M | $78.0M | $14.4M |
| Dividends paid | $4.0M | $0.0M | $0.0M | — | — | — |
| Dividends and buybacks | $4.0M | $3.4M | $0.3M | $21.6M | $78.0M | $14.4M |
| Balance sheet | ||||||
| Cash and short-term investments | $57.8M | $48.8M | $57.4M | $62.7M | $15.4M | $32.6M |
| Total debt | — | $15.7M | $1.0M | $2.2M | $2.4M | $2.5M |
| Finance lease liabilities | — | $0.7M | $1.0M | $1.5M | $1.6M | $1.7M |
| Current assets | — | $142M | $159M | $180M | $146M | $180M |
| Current liabilities | — | $97.8M | $73.3M | $71.0M | $79.9M | $85.5M |
| Goodwill | — | $11.8M | $11.8M | $11.8M | $11.8M | $11.8M |
| Total assets | — | $294M | $293M | $294M | $273M | $309M |
| Total liabilities | — | $181M | $143M | $128M | $139M | $139M |
| Shareholders' equity | $94.7M | $113M | $150M | $166M | $134M | $170M |
| Margins | ||||||
| Operating margin | 3.8% | 4.2% | 7.7% | 7.8% | 8.3% | 8.5% |
| EBITDA margin | 7.0% | 7.9% | 11.4% | 11.6% | 11.4% | 11.6% |
| Net margin | 3.0% | 4.4% | 6.0% | 6.6% | 6.6% | 7.2% |
| FCF margin | −1.1% | 2.9% | 4.4% | 5.3% | 4.9% | 4.8% |
| Returns | ||||||
| Return on capital | — | 25.7% | 33.9% | 30.8% | 30.8% | 33.5% |
| Return on capital employed | — | 10.5% | 18.4% | 17.7% | 24.1% | 24.6% |
| Return on equity | 13.8% | 20.6% | 24.0% | 21.3% | 24.6% | 30.4% |
| Return on assets | — | 7.3% | 10.8% | 11.5% | 13.0% | 15.9% |
| Return on tangible equity | 13.8% | 21.1% | 22.9% | 21.9% | 30.1% | 29.2% |
| Growth | ||||||
| Revenue growth | — | 11.2% | 6.1% | −2.8% | 9.8% | 15.4% |
| Net income growth | — | 63.9% | 47.2% | 6.6% | 9.5% | 25.7% |
| EPS growth | — | 62.0% | 45.2% | 10.2% | 28.3% | 32.6% |
| FCF growth | — | — | 62.6% | 18.1% | 0.9% | 14.3% |
| Share count change | — | 2.0% | 0.9% | −3.4% | −13.9% | −5.8% |
| Financial health | ||||||
| Net debt / EBITDA | — | −0.8x | −0.9x | −1.0x | −0.2x | −0.4x |
| Debt / equity | — | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 9.0x | 16.0x | 51.1x | 76.7x | 28.5x | 58.7x |
| Current ratio | — | 1.5x | 2.2x | 2.5x | 1.8x | 2.1x |
| Quick ratio | — | 1.5x | 2.2x | 2.5x | 1.8x | 2.1x |
| Capital allocation | ||||||
| Capex / revenue | 4.7% | 5.3% | 3.6% | 1.7% | 3.3% | 4.3% |
| Stock comp / revenue | 1.2% | 0.4% | 0.9% | 0.7% | 1.0% | 1.2% |
| Payouts / FCF | — | 24.2% | 1.2% | 79.7% | 285.8% | 46.1% |
| Quality scores | ||||||
| Piotroski F-score | — | — | 7.0 | 6.0 | 6.0 | 8.0 |
| Altman Z'' | — | 1.3 | 3.4 | 4.6 | 4.0 | 5.2 |
| Accruals ratio | — | −6.3% | −3.5% | −0.8% | −3.1% | −4.4% |
Source: SEC EDGAR XBRL filings (CIK 0001720420). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
